About FISHFA BIOGENICS
FISHFA BIOGENICS is a company based in Rajkot (India) founded in 2017. It operates as a B2B. FISHFA BIOGENICS offers products and services including Tacrolimus API, Cyclosporine API, Mupirocin API, and Mupirocin Calcium. FISHFA BIOGENICS operates in a competitive market with competitors including Ginkgo Bioworks, Kula Bio, Pivot Bio, Pluton Biosciences and BioConsortia, among others.
- Headquarter Rajkot, India
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Fishfa Biogenics Limited
- Date of Incorporation 28 Mar, 2019
- Jurisdiction Rajkot, Gujarat, India
-
Annual Revenue
-
Net Profit
-$245.95 (USD)72.63as on Mar 31, 2022
-
EBITDA
-$64.48 (USD)92.82as on Mar 31, 2022
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of FISHFA BIOGENICS
FISHFA BIOGENICS offers a comprehensive portfolio of products and services, including Tacrolimus API, Cyclosporine API, Mupirocin API, and Mupirocin Calcium.
Fermentation-based API for preventing organ transplant rejection.
API used in therapies to suppress immune responses.
Fermentation-based API for treating bacterial infections.
API variant for enhanced bacterial infection treatment.
People of FISHFA BIOGENICS
Unlock access to complete
Unlock access to complete
Funding Insights of FISHFA BIOGENICS
Investments & Acquisitions by FISHFA BIOGENICS
Financial Statements - FISHFA BIOGENICS
Fishfa Biogenics Comparisons
Competitors of FISHFA BIOGENICS
FISHFA BIOGENICS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ginkgo Bioworks, Kula Bio, Pivot Bio, Pluton Biosciences and BioConsortia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Gene editing-based cultured ingredients are provided for agriculture.
|
|
| domain | founded_year | HQ Location |
Manufacturer of microbial crop nutrition products
|
|
| domain | founded_year | HQ Location |
Nitrogen-fixing microbes for corn crop nutrition are developed and applied.
|
|
| domain | founded_year | HQ Location |
Assay-based microbial research services are offered for industrial applications.
|
|
| domain | founded_year | HQ Location |
Microbial biotech solutions for enhancing crop yields are developed.
|
|
| domain | founded_year | HQ Location |
Crop inputs are supplied using beneficial plant bacteria for agriculture.
|
Latest news on Fishfa Biogenics
Frequently Asked Questions about FISHFA BIOGENICS
FISHFA BIOGENICS was founded in 2017.
FISHFA BIOGENICS is headquartered in Rajkot, India. It is registered at Rajkot, Gujarat, India.
Fishfa Biogenics is a biopharmaceutical company based in Rajkot, India, specializing in manufacturing fermentation-based Active Pharmaceutical Ingredients like Tacrolimus and Cyclosporine. They focus on high-quality production for immunosuppressants, antibiotics, and antifungals, serving the global market through innovative processes and state-of-the-art facilities. The company emphasizes quality control and sustainability in its operations.
FISHFA BIOGENICS's top competitors include Ginkgo Bioworks, Pivot Bio and Kula Bio.
FISHFA BIOGENICS offers Tacrolimus API, Cyclosporine API, Mupirocin API, and Mupirocin Calcium.